I can't believe LTR hasn't received initial assays for Bynoe Phase 2 drilling. The weakness in the share price and the dramatic fall in CXO is interesting. These two companies are so close maybe the geos are talking over the fence about the weather and the weather may not be too good on one side.
Who knows but its clear LTR needs a good assay result to prop the two company share rices up over the wet.
- Forums
- ASX - By Stock
- Days Like These
I can't believe LTR hasn't received initial assays for Bynoe...
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
87.5¢ |
Change
0.035(4.17%) |
Mkt cap ! $2.121B |
Open | High | Low | Value | Volume |
85.0¢ | 89.5¢ | 84.5¢ | $14.42M | 16.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 87.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.5¢ | 79469 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 0.870 |
4 | 93230 | 0.865 |
5 | 77327 | 0.860 |
4 | 161823 | 0.855 |
10 | 425000 | 0.850 |
Price($) | Vol. | No. |
---|---|---|
0.875 | 79469 | 3 |
0.880 | 20475 | 3 |
0.885 | 7190 | 2 |
0.890 | 340248 | 14 |
0.895 | 160337 | 15 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online